Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Brachydactyly - arterial hypertension is a rare genetic brachydactyly syndrome characterized by the association of brachydactyly type E with hypertension (due to vascular or neurovascular anomalies) as well as the additional features of short stature and low birth weight (compared to non-affected family members), stocky build and a round face. The onset of hypertension is often in childhood and, if untreated, most patients will have had a stroke by the age of 50.
Features include always present findings: Short stature and Hypertension; and very common findings: Type E brachydactyly. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Growth and development | 1 | Short stature |
Heart and blood vessels |
PDE3A function has not been fully characterized.
Brachydactyly-arterial hypertension syndrome is associated with mutations in the PDE3A gene on chromosome 12.
Genetic testing for PDE3A is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for brachydactyly-arterial hypertension syndrome has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 1 very common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for brachydactyly-arterial hypertension syndrome.
204 publications have been identified in PubMed for brachydactyly-arterial hypertension syndrome. Research spans Review / Meta-Analysis (39%), Epidemiology / Natural History (28%), and Basic Science / Preclinical (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 66 | 39% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 12:15 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Hypertension |
Arms and legs | 1 | Short phalanx of finger |
Disease patterns and progression
48 |
28% |
Laboratory research | 24 | 14% |
Clinical study results | 11 | 6% |
Patient case studies | 9 | 5% |
Testing and diagnosis research | 8 | 5% |
New treatment approaches | 3 | 2% |
Other research | 1 | 1% |
Pandey S (2026). [PMID: 38493776](https://pubmed.ncbi.nlm.nih.gov/38493776/). *Am J Nephrol*. [Review / Meta-Analysis]
Foroshani S (2026). [PMID: 38400720](https://pubmed.ncbi.nlm.nih.gov/38400720/). *Cardiol Rev*. [Review / Meta-Analysis]
Jose A (2026). [PMID: 41581020](https://pubmed.ncbi.nlm.nih.gov/41581020/). *Current opinion in critical care*. [Review / Meta-Analysis]
Nordin P (2026). [PMID: 42031484](https://pubmed.ncbi.nlm.nih.gov/42031484/). *BMJ Open*. [Epidemiology / Natural History]
Yang X (2026). [PMID: 40696512](https://pubmed.ncbi.nlm.nih.gov/40696512/). *J Sleep Res*. [Basic Science / Preclinical]
Chacko SR (2026). [PMID: 41466357](https://pubmed.ncbi.nlm.nih.gov/41466357/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Li G (2026). [PMID: 41721701](https://pubmed.ncbi.nlm.nih.gov/41721701/). *Clinical and experimental hypertension (New York, N.Y. : 1993)*. [Review / Meta-Analysis]
Ozkara E (2026). [PMID: 41936443](https://pubmed.ncbi.nlm.nih.gov/41936443/). *Neurol Med Chir (Tokyo)*. [Diagnostic / Biomarker]
Niu ZJ (2026). [PMID: 41580679](https://pubmed.ncbi.nlm.nih.gov/41580679/). *Cardiovasc Diabetol*. [Epidemiology / Natural History]
Mulatero P (2026). [PMID: 41638800](https://pubmed.ncbi.nlm.nih.gov/41638800/). *Vitam Horm*. [Review / Meta-Analysis]